{"id":"https://openalex.org/W2761620719","doi":"https://doi.org/10.1093/annonc/mdy151.259","title":"Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI: Interim results of the non-interventional AIO study QoLiTrap","display_name":"Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI: Interim results of the non-interventional AIO study QoLiTrap","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2761620719","doi":"https://doi.org/10.1093/annonc/mdy151.259","mag":"2761620719"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdy151.259","doi":"https://doi.org/10.1093/annonc/mdy151.259","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy151.259","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1093/annonc/mdy151.259","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044867224","display_name":"Mark\u2010Oliver Zahn","orcid":"https://orcid.org/0000-0002-0528-5311","observed_orcids":["https://orcid.org/0000-0002-0528-5311"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Zahn","raw_affiliation_strings":["Onkologie/H\u00e4matologie Goslar, Goslar, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Onkologie/H\u00e4matologie Goslar, Goslar, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113011177","display_name":"Felicitas Scholten","orcid":"https://orcid.org/0009-0008-7197-4255","observed_orcids":["https://orcid.org/0009-0008-7197-4255"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Scholten","raw_affiliation_strings":["Klinikum Frankfurt Hoechst GmbH, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinikum Frankfurt Hoechst GmbH, Frankfurt am Main, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025804381","display_name":"Roger von Moos","orcid":"https://orcid.org/0000-0003-2362-8514","observed_orcids":["https://orcid.org/0000-0003-2362-8514"]},"institutions":[{"id":"https://openalex.org/I4210148531","display_name":"Kantonsspital Graub\u00fcnden","ror":"https://ror.org/04wpn1218","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210148531"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"R. von Moos","raw_affiliation_strings":["Kantonsspital Graubuenden, Chur, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kantonsspital Graubuenden, Chur, Switzerland","institution_ids":["https://openalex.org/I4210148531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039285562","display_name":"J. Thaler","orcid":"https://orcid.org/0000-0002-9613-8658","observed_orcids":["https://orcid.org/0000-0002-9613-8658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Thaler","raw_affiliation_strings":["Dept Internal Medicine, Wels, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept Internal Medicine, Wels, Austria","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052177007","display_name":"Ralf\u2010Dieter Hofheinz","orcid":"https://orcid.org/0000-0001-5972-8504","observed_orcids":["https://orcid.org/0000-0001-5972-8504"]},"institutions":[{"id":"https://openalex.org/I4210156450","display_name":"University Medical Centre Mannheim","ror":"https://ror.org/05sxbyd35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210156450"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"R. Hofheinz","raw_affiliation_strings":["University Hospital Mannheim, Mannheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Mannheim, Mannheim, Germany","institution_ids":["https://openalex.org/I4210156450"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":{"value":5080,"currency":"USD","value_usd":5080},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00241888,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":null,"first_page":"v73","last_page":"v73"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9110000133514404},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":0.996999979019165},{"id":"https://openalex.org/keywords/folfiri","display_name":"FOLFIRI","score":0.996999979019165},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9419999718666077},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/vegf-a","display_name":"VEGF-A","score":0.7730000019073486},{"id":"https://openalex.org/keywords/vegf-b","display_name":"VEGF-B","score":0.9020000100135803},{"id":"https://openalex.org/keywords/placental-growth-factor","display_name":"placental growth factor","score":0.9890000224113464},{"id":"https://openalex.org/keywords/oxaliplatin-refractory-disease","display_name":"oxaliplatin-refractory disease","score":0.8489999771118164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.954105019569397},{"id":"https://openalex.org/C2776705615","wikidata":"https://www.wikidata.org/wiki/Q1389369","display_name":"FOLFIRI","level":5,"score":0.9385265111923218},{"id":"https://openalex.org/C2778749236","wikidata":"https://www.wikidata.org/wiki/Q4689286","display_name":"Aflibercept","level":4,"score":0.9371265172958374},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7336438298225403},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7030836343765259},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.6186631917953491},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5368870496749878},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.46637824177742004},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.46501854062080383},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.4451625347137451},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.4201432168483734},{"id":"https://openalex.org/C2776248978","wikidata":"https://www.wikidata.org/wiki/Q3891664","display_name":"Regorafenib","level":4,"score":0.4101239740848541},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3302614986896515},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32928580045700073},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.17275181412696838}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/annonc/mdy151.259","doi":"https://doi.org/10.1093/annonc/mdy151.259","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy151.259","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdy151.259","doi":"https://doi.org/10.1093/annonc/mdy151.259","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy151.259","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2955816305","https://openalex.org/W2977528322","https://openalex.org/W3169456662","https://openalex.org/W2898221561","https://openalex.org/W2591370666","https://openalex.org/W2887924383","https://openalex.org/W2588586288","https://openalex.org/W4286209289","https://openalex.org/W3200810338","https://openalex.org/W2338859975"],"abstract_inverted_index":{"Introduction:":[0],"The":[1],"anti-angiogenic":[2],"fusion":[3],"protein":[4],"aflibercept":[5],"targets":[6],"VEGF-A,":[7],"VEGF-B":[8],"and":[9],"PlGF.":[10],"Aflibercept":[11],"is":[12,23],"approved":[13],"in":[14],"combination":[15],"with":[16],"FOLFIRI":[17],"for":[18],"treatment":[19],"of":[20],"mCRC":[21],"that":[22],"resistant":[24],"or":[25],"has":[26],"progressed":[27],"after":[28],"oxaliplatin-containing":[29],"therapy.":[30]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2017-10-20T00:00:00"}